Insulin secretion action patients pancreatic cancer authors insulin secretory capacity insulin action preoperative patients pancreatic carcinoma age-matched weight-matched healthy subjects patients diabetic impaired glucose tolerant IGT nondiabetic ND Postabsorptive serum insulin levels mean SE uU/ml IGT ND comparable administration oral glucose peak insulin IGT ND whereas insulin levels IGT ND Comparable insulin response stimuli subjects slow arginine infusion test mean serum insulin IGT ND patients controls insulin action euglycemic hyperinsulinemic clamp technique glucose turnover rates glucose infusion Steady-state plasma glucose concentrations mg/dl insulin infusion rate mU/kg/min comparable high physiologic insulin levels uU/ml uU/ml Postabsorptive rates endogenous glucose appearance Ra mg/kg/min mg/kg/min high physiologic insulin concentrations negative Ra values subjects complete suppression Ra Total body glucose use mg/kg/min mg/kg/min consistent state insulin resistance Patients pancreatic cancer insulin resistance virtue decrease total body glucose use decreased insulin response due inherent beta cell dysfunction islet cell mass latter identifiable histologic morphology 